For the Inventor, By the Inventor

Enter assignee name

Iselin, NJ, United States of America

Bio-technology General Corporation

USPTO Granted Patents = 67

EPO Patents = 2

Forward Citations = 944

Loading Chart...

Loading Chart...

50 inventors (with patents filed for the assignee):

Avigdor Levanon (26 out of 28 patents)

Amos B Oppenheim (20 out of 23 patents)

Marian Gorecki (19 out of 21 patents)

4. Jacob R Hartman (15 out of 32 patents)

5. Tikva Vogel (14 out of 15 patents)

6. Moshe M Werber (12 out of 13 patents)

7. Haim Aviv (10 out of 16 patents)

8. Elisha P Zeelon (10 out of 10 patents)

9. Meir Fischer (8 out of 8 patents)

10. Rachel Guy (7 out of 9 patents)

11. Amos Panet (7 out of 8 patents)

12. Yaffa Beck (6 out of 6 patents)

13. Menachem Zeevi (5 out of 5 patents)

14. Benjamin Greenman (5 out of 5 patents)

15. Hilla Locker-Giladi (4 out of 4 patents)

Core Competencies:

Human Immunodeficiency Virus

Manganese Superoxide Dismutase

Oxandrolone Treatment

Factor Xa Inhibitory Activity

Fibrin Binding Domain Polypeptides

Recombinant Polypeptides

Expression Vectors

Chronic Obstructive Pulmonary Disease

Superoxide Dismutase Compositions

Human Growth Hormone

Apolipoprotein E

Hepatitis B Vaccine

67 patents: Sort by Forward Citations

1. 6670351 - Method for ameliorating muscle weakness/wasting in a patient infected with human immunodeficiency virus-type 1 (2003-12-30),

2. 6610520 - Gene encoding human manganese superoxide dismutase and recombinant polypeptide encoded thereby (2003-08-26),

3. 6576659 - Use of oxandrolone in the treatment of burns an other wounds (2003-06-10),

4. 6361772 - Human manganese superoxide dismutase DNA, its expression and method of recovering human manganese superoxide dismutase (2002-03-26),

5. 6211341 - Polypeptide having factor Xa inhibitory activity (2001-04-03),

6. 6121426 - Fibrin binding domain polypeptides and uses and methods of producing same (2000-09-19),

7. 6054291 - Expression vectors for enhanced production of polypeptides, plasmids (2000-04-25),

8. 6030611 - Therapeutic SOD compositions and uses thereof (2000-02-29),

9. 6010875 - Expressions plasmids containing the deo promoter, and bacterial hosts (2000-01-04),

10. 6008193 - Methods of using human von Willebrand factor GPIb binding domain (1999-12-28),

11. 6001604 - Refolding of proinsulins without addition of reducing agents (1999-12-14),

12. 5965383 - Fibrin binding domain polypeptides and uses and methods of producing same (1999-10-12),

13. 5948668 - Production of enzymatically active recombinant carboxypeptidase B (1999-09-07),

14. 5945304 - Expression plasmids regulated by an osmB promoter (1999-08-31),

15. 5872147 - Use of oxandrolone in the treatment of chronic obstructive pulmonary (1999-02-16),

Bio-Technology General Corporation is a biotechnology company specializing in the development, manufacturing, and commercialization of novel therapeutics and diagnostic products. With a focus on genetic engineering and molecular biology, the company aims to develop innovative solutions for various medical conditions and improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 23 2025

67 Patents

#4 in Iselin, NJ

#227 in New Jersey

#5,219 in US

#10,603 in the World

Iselin, NJ, United States of America

Bio-technology General Corporation

Forward Citations = 944

50 inventors:

Avigdor Levanon (26 out of 28 patents)

Amos B Oppenheim (20 out of 23 patents)

Marian Gorecki (19 out of 21 patents)

4. Jacob R Hartman (15 out of 32 patents)

5. Tikva Vogel (14 out of 15 patents)

Please report any incorrect information to support@idiyas.com

Loading…